Mitzi Cloud serves as the Vice President and Head of Commercial for North America at MedTrace Pharma A/S, where she plays a pivotal role in the launch of innovative solutions in nuclear cardiology. With over 20 years of experience in the pharmaceutical, biotech, and medical...
Mitzi Cloud serves as the Vice President and Head of Commercial for North America at MedTrace Pharma A/S, where she plays a pivotal role in the launch of innovative solutions in nuclear cardiology. With over 20 years of experience in the pharmaceutical, biotech, and medical device sectors, Mitzi is recognized for her strategic acumen and proven ability to build high-performing teams and brands. Currently, she is spearheading the design and establishment of a comprehensive commercial organization for the groundbreaking 15O-water product, which is in Phase 3 and pending FDA approval for identifying coronary artery disease (CAD) using positron emission tomography (PET).
Mitzi's expertise encompasses a wide range of commercial leadership functions, including sales, marketing, market access, and operations. Her in-depth knowledge of pricing strategies and market access is crucial as she navigates the complex regulatory landscape that involves the simultaneous review of drug, device, and software components under a single New Drug Application (NDA). By conducting thorough market landscape analyses and assessing competitive dynamics, she is adept at identifying market trends that inform go-to-market strategies.
Her customer-focused approach and commitment to mentorship foster a culture of collaboration and innovation within her teams. Mitzi's skills in key account development and change management are instrumental in driving successful product launches and new business development initiatives. As she leads MedTrace Pharma's efforts in revolutionizing nuclear cardiology, her strategic vision and operational expertise position the company for significant growth and impact in the healthcare landscape.
